Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)

NCT03520751 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT03520751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Trial Evaluating scAAV1.tMCK.NTF3 for Treatment of Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 1/2
Overall status
Withdrawn
Start date
April 30, 2027
Completion date
April 30, 2030
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

charcot-marie-tooth neuropathy type 1a